Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FDPS | P14324 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11721273 | 0.88 | FDPS (0.35) | FDPS | |
| SCHEMBL23740307 | 0.82 | FDPS (0.39) | FDPS | |
| SCHEMBL1684218 | 0.82 | — | — | |
| SCHEMBL24924110 | 0.80 | SMPD1 (0.41) | FDPS | |
| SCHEMBL27605324 | 0.79 | — | — | |
| SCHEMBL24361086 | 0.79 | FDPS (0.30) | FDPS | |
| SCHEMBL29391647 | 0.79 | FDPS (0.34) | FDPS | |
| SCHEMBL1137826 | 0.79 | FDPS (0.30) | FDPS | |
| SCHEMBL11774755 | 0.74 | FDPS (0.33) | FDPS | |
| SCHEMBL26831160 | 0.74 | LMNA (0.37) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 142 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3578541-B1 | COMPOSITIONS COMPRISING MOLECULES HAVING PESTICIDAL UTILITY, AND PROCESSES RELATED THERETO | CORTEVA AGRISCIENCE LLC (US) | 2025-05-28 | — | — | EP | disclosed |
| EP-3215172-B1 | MODIFICATIONS AND USES OF CONOTOXIN PEPTIDES | KINETA CHRONIC PAIN LLC (US) | 2023-04-26 | — | — | EP | disclosed |
| US-11618772-B2 | Modifications and uses of conotoxin peptides | KINETA CHRONIC PAIN, LLC | 2023-04-04 | — | — | US | disclosed |
| US-11014970-B2 | Modifications and uses of conotoxin peptides | KINETA CHRONIC PAIN, LLC (US) | 2021-05-25 | — | — | US | disclosed |
| US-20210122792-A1 | MODIFICATIONS AND USES OF CONOTOXIN PEPTIDES | KINETA CHRONIC PAIN, LLC (US) | 2021-04-29 | — | — | US | disclosed |
| US-10947274-B1 | Synthetic analgesic peptides of RgIA analogs | UNIVERSITY OF UTAH RESEARCH FOUNDATION (US) | 2021-03-16 | — | — | US | disclosed |
| EP-3003344-B1 | CONOTOXIN PEPTIDES, PHARMACEUTICAL COMPOSITIONS AND USES THEREOF | UNIV UTAH RES FOUND (US) | 2020-11-25 | — | — | EP | disclosed |
| US-10633417-B2 | Conotoxin peptides, pharmaceutical compositions and uses thereof | UNIVERSITY OF UTAH RESEARCH FOUNDATION (US) | 2020-04-28 | — | — | US | disclosed |
| EP-3578541-A1 | MOLECULES HAVING PESTICIDAL UTILITY, AND INTERMEDIATES, COMPOSITION, AND PROCESSES, RELATED THERETO | Dow AgroSciences LLC (US) | 2019-12-11 | — | — | EP | disclosed |
| US-10399932-B2 | Inhibitors of indoleamine-2,3-dioxygenase for the treatment of cancer | BRISTOL-MYERS SQUIBB COMPANY (US) | 2019-09-03 | — | — | US | disclosed |
| WO-2000044769-A1 | CONOTOXIN PEPTIDES | UNIVERSITY OF UTAH RESEARCH FOUNDATION (US) | 2000-08-03 | — | — | WO | disclosed |
| WO-2000043409-A2 | ALPHA-CONOTOXIN PEPTIDES | UNIVERSITY OF UTAH RESEARCH FOUNDATION (US) | 2000-07-27 | — | — | WO | disclosed |
| EP-0964691-A1 | USE OF CONANTOKINS | Cognetix, Inc. (US) | 1999-12-22 | — | — | EP | disclosed |
| EP-0956292-A1 | CONANTOKINS | UNIVERSITY OF UTAH RESEARCH FOUNDATION (US) | 1999-11-17 | — | — | EP | disclosed |
| US-5719280-A | REACTING AMINE SUBSTITUTED BENZOCYCLOALKANE WITH DIALKYLOXYACETALDEHYDE IN PRESENCE OF REDUCING AGENT OR CATALYTIC HYDROGENATION, TREATING WITH THIOCYANIC ACID | SYNTEX (U.S.A.) INC. (US) | 1998-02-17 | — | — | US | disclosed |
| WO-1998003189-A1 | USE OF CONANTOKINS | COGNETIX, INC. (US) | 1998-01-29 | — | — | WO | disclosed |
| WO-1998003541-A1 | CONANTOKINS | UNIVERSITY OF UTAH RESEARCH FOUNDATION (US) | 1998-01-29 | — | — | WO | disclosed |
| EP-0757677-A1 | BENZOCYCLOALKYLAZOLETHIONE DERIVATIVES | SYNTEX (U.S.A.) INC. (US) | 1997-02-12 | — | — | EP | disclosed |
| US-5538988-A | CARDIOVASCULAR DISORDERS AND DOPAMINE HYDROLASE ENZYME INHIBITORS | SYNTEX (U.S.A.) INC. | 1996-07-23 | — | — | US | disclosed |
| WO-1995029165-A2 | BENZOCYCLOALKYLAZ0LETHIONE DERIVATIVES AS DOPAMIN BETA-HYDROXYLASE INHIBITORS | SYNTEX (U.S.A.) INC. (US) | 1995-11-02 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210122792-A1 | MODIFICATIONS AND USES OF CONOTOXIN PEPTIDES | CHRNA9, CHRNA10, CHRNA7 | FDPS 4150/4885 |
| US-11618772-B2 | Modifications and uses of conotoxin peptides | CHRNA9, CHRNA10, CHRNA7 | FDPS 4150/4885 |
| US-10399932-B2 | Inhibitors of indoleamine-2,3-dioxygenase for the treatment of cancer | IDO1, IDO2, INMT | FDPS 1494/4885 |
| US-11014970-B2 | Modifications and uses of conotoxin peptides | CHRNA9, CHRNA10, CHRNA7 | FDPS 4150/4885 |
| US-10947274-B1 | Synthetic analgesic peptides of RgIA analogs | QRFPR, OPRL1, VIP | FDPS 3090/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.